Label

How We Work

Grant

Back

Print

The General Hospital Corporation d/b/a Massachusetts General Hospital


October 2008
to design a conjugate which will attach to the GP63 enzyme of the Leishmania parasite, creating a lightactivatable, non-toxic chemical therapy that will be activated by a light source, killing the parasite but leaving surrounding cells intact
$100,000
18
Discovery and Translational Sciences
Global Health
Boston, Massachusetts
http://www.massgeneral.org/

Visit Our Blog